Probable multifocal bullous fixed drug eruption
Allan Zhou
,
Eden Chan
,
Eunizar Omar
Year:
2026
Background: Fixed drug eruptions (FDEs) are a form of delayed-type hypersensitivity mediated by CD8+ T cells triggered by offending agents resulting in recurrent lesions. Multifocal bullous subtypes are rarer but do exist and can mimic other blistering diseases posing a diagnostic challenge in the emergency department setting. Case Presentation: A 54-year-old Malay lady presented to the emergency department with a painful blistering rash over bilateral extensor forearm and elbow. They appeared as dusky, well-demarcated round plaques with central tense bullae. She had six to seven similar episodes over the past two years, recurring every three to four months with self-resolution each time. Skin biopsy demonstrated superficial perivascular dermatitis with pigmentary incontinence. Direct immunofluorescence and autoimmune serology with blistering disease BP 180 and BP 230 were negative. These findings support a diagnosis of probable multifocal bullous fixed drug eruption. The culprit agent was not identified, and the patient was advised for...
Continue Reading
Assessment and evaluation of pain management in oncology patients presented to the emergency department
Ahmad Mahmoud Wazzan
,
Moudi Alasmari
,
Yaser Rambo
,
Abdullah Murshid
,
Nawaf Alharthy
,
Abdulrahman Qurunfulah
,
Abdulellah Alqudsi
Year:
2026
Objective: This study aimed to evaluate the pain management practices for oncology patients in the emergency department (ED), focusing on pain assessment, analgesic use, and treatment effectiveness.Methods: This retrospective cohort study was conducted at King Abdulaziz Medical City in Jeddah, Saudi Arabia, from January 2020 to December 2023. A total of 341 oncology patients who presented to the ED with pain were included. As pain scores for most patients were missing, observed values were retained, and a transparent, conservative approach was used to estimate missing scores to enable inferential analyses. The primary outcome was effective pain relief (≥2-point reduction, 0–10 scale).Results: The mean age was 54 years, and 47% of participants were male. Pre-treatment pain scores were documented in 18% of patients; reassessment after analgesia was recorded in 28%. The mean pain score decreased from 7.4 pre-treatment to 1.6 post-treatment (p < 0.001). Opioid use was associated with greater odds...
Continue Reading